175 related articles for article (PubMed ID: 36460547)
1. Immunotherapy Options for Acral Melanoma, A fast-growing but Neglected Malignancy.
Gajón JA; Juarez-Flores A; De León Rodríguez SG; Aguilar Flores C; Mantilla A; Fuentes-Pananá EM; Bonifaz LC
Arch Med Res; 2022 Dec; 53(8):794-806. PubMed ID: 36460547
[TBL] [Abstract][Full Text] [Related]
2. Acral melanoma: new insights into the immune and genomic landscape.
Carvalho LAD; Aguiar FC; Smalley KSM; Possik PA
Neoplasia; 2023 Dec; 46():100947. PubMed ID: 37913653
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions.
Mao L; Qi Z; Zhang L; Guo J; Si L
Front Immunol; 2021; 12():680407. PubMed ID: 34149718
[TBL] [Abstract][Full Text] [Related]
4. Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy.
Li J; Smalley I; Chen Z; Wu JY; Phadke MS; Teer JK; Nguyen T; Karreth FA; Koomen JM; Sarnaik AA; Zager JS; Khushalani NI; Tarhini AA; Sondak VK; Rodriguez PC; Messina JL; Chen YA; Smalley KSM
Clin Cancer Res; 2022 May; 28(10):2131-2146. PubMed ID: 35247927
[TBL] [Abstract][Full Text] [Related]
5. Mapping the single-cell landscape of acral melanoma and analysis of the molecular regulatory network of the tumor microenvironments.
He Z; Xin Z; Yang Q; Wang C; Li M; Rao W; Du Z; Bai J; Guo Z; Ruan X; Zhang Z; Fang X; Zhao H
Elife; 2022 Jul; 11():. PubMed ID: 35894206
[TBL] [Abstract][Full Text] [Related]
6. Translational pathology, genomics and the development of systemic therapies for acral melanoma.
Chen YA; Teer JK; Eroglu Z; Wu JY; Koomen JM; Karreth FA; Messina JL; Smalley KSM
Semin Cancer Biol; 2020 Apr; 61():149-157. PubMed ID: 31689494
[TBL] [Abstract][Full Text] [Related]
7. Management of Acral and Mucosal Melanoma: Medical Oncology Perspective.
Jung S; Johnson DB
Oncologist; 2022 Aug; 27(8):703-710. PubMed ID: 35640549
[TBL] [Abstract][Full Text] [Related]
8. Melanoma in non-caucasian populations.
Stubblefield J; Kelly B
Surg Clin North Am; 2014 Oct; 94(5):1115-26, ix. PubMed ID: 25245971
[TBL] [Abstract][Full Text] [Related]
9. Targeted Genomic Profiling of Acral Melanoma.
Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
[TBL] [Abstract][Full Text] [Related]
10. Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma.
Gui J; Guo Z; Wu D
J Transl Med; 2022 Aug; 20(1):367. PubMed ID: 35974375
[TBL] [Abstract][Full Text] [Related]
11. Advanced Acral Melanoma Therapies: Current Status and Future Directions.
Zhang Y; Lan S; Wu D
Curr Treat Options Oncol; 2022 Oct; 23(10):1405-1427. PubMed ID: 36125617
[TBL] [Abstract][Full Text] [Related]
12. More than just acral melanoma: the controversies of defining the disease.
Bernardes SS; Ferreira I; Elder DE; Nobre AB; Martínez-Said H; Adams DJ; Robles-Espinoza CD; Possik PA
J Pathol Clin Res; 2021 Nov; 7(6):531-541. PubMed ID: 34213090
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous and acral melanoma cross-OMICs reveals prognostic cancer drivers associated with pathobiology and ultraviolet exposure.
Vicente ALSA; Novoloaca A; Cahais V; Awada Z; Cuenin C; Spitz N; Carvalho AL; Evangelista AF; Crovador CS; Reis RM; Herceg Z; de Lima Vazquez V; Ghantous A
Nat Commun; 2022 Jul; 13(1):4115. PubMed ID: 35840550
[TBL] [Abstract][Full Text] [Related]
14. Recent advancements in the diagnosis and treatment of acral melanoma.
Alhaskawi A; Ezzi SHA; Dong Y; Zhou H; Wang Z; Lai J; Yao C; Kota VG; Abdulla MHAH; Lu H
J Zhejiang Univ Sci B; 2024 Feb; 25(2):106-122. PubMed ID: 38303495
[TBL] [Abstract][Full Text] [Related]
15. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).
Di Carlo V; Stiller CA; Eisemann N; Bordoni A; Matz M; Curado MP; Daubisse-Marliac L; Valkov M; Bulliard JL; Morrison D; Johnson C; Girardi F; Marcos-Gragera R; Šekerija M; Larønningen S; Sirri E; Coleman MP; Allemani C;
Br J Dermatol; 2022 Sep; 187(3):364-380. PubMed ID: 35347700
[TBL] [Abstract][Full Text] [Related]
16. Distinct sets of genetic alterations in melanoma.
Curtin JA; Fridlyand J; Kageshita T; Patel HN; Busam KJ; Kutzner H; Cho KH; Aiba S; Bröcker EB; LeBoit PE; Pinkel D; Bastian BC
N Engl J Med; 2005 Nov; 353(20):2135-47. PubMed ID: 16291983
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional study of acral melanoma awareness in a group of South African final phase medical students.
Eksteen JM; Visser WI; de Wet J; Lombard C; Zunza M; Tod B
Indian J Dermatol Venereol Leprol; 2022; 88(3):444. PubMed ID: 35389032
[TBL] [Abstract][Full Text] [Related]
18. Management of acral lentiginous melanoma: current updates and future directions.
Dugan MM; Perez MC; Karapetyan L; Zager JS
Front Oncol; 2024; 14():1323933. PubMed ID: 38390259
[TBL] [Abstract][Full Text] [Related]
19. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.
Handolias D; Salemi R; Murray W; Tan A; Liu W; Viros A; Dobrovic A; Kelly J; McArthur GA
Pigment Cell Melanoma Res; 2010 Apr; 23(2):210-5. PubMed ID: 20088873
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and Management of Acral Lentiginous Melanoma.
Nakamura Y; Fujisawa Y
Curr Treat Options Oncol; 2018 Jun; 19(8):42. PubMed ID: 29951919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
